Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Atlanta, GA, June 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
-
GeoVax Chairman & CEO to Participate in Vaccine Panel Discussion ATLANTA, GA, June 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...
-
Additional Capital Raised to Support Acceleration ofCoronavirus and Immuno-Oncology Programs ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a...
-
GeoVax Chairman & CEO David Dodd to Participate in Panel Discussion ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology...
-
Conference call to be held Thursday, May 6, at 4:30 p.m. Eastern Time ATLANTA, GA, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the...
-
Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the...
-
COVID-19 Vaccine Designed as Single-Dose Against Multiple Strains Immuno-Oncology Programs Advancing ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via...
-
GeoVax Chairman & CEO David Dodd to Present Corporate OverviewGeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 17, 2021 (GLOBE NEWSWIRE) --...
-
Conference call to be held Wednesday, March 24, at 8:00 a.m. Eastern Time ATLANTA, GA, March 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology...
-
GeoVax Chairman & CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 10, 2021 (GLOBE NEWSWIRE) --...